Amber List

TARSTarsus Pharmaceuticals, Inc.

Healthcare · Biotechnology · mid-cap ($2.7B)
-30.2%
from rolling 252-day high of $85.25 set 2025-12-09 · 170d ago
Current
$59.54
Decline depth
-30.2%
Decline σ
3.5σ
TFC
2/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$TARS landed on the list 2026-03-14, down 19.2% from its 52-week high that day — now down -30.2%.

That's 11.3 percentage points deeper than the day it joined.

Decline from the 52-week high as it stood on 2026-03-16 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

TARS qualifies for the Amber List on decline depth.

Decline depth
-30.2%
From rolling 252-day high of $85.25, 170d ago. Past the 30% Amber threshold.
Time-frame continuity
2/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
3.5σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (3.16% per day).

The structural read

What price action says about TARS.

TARS qualifies for the Amber List on decline depth — down -30.2% from its rolling 252-day high.

Earnings on file: 2026-05-06. Tiering is unaffected by earnings dates — listings reflect price structure only.

52-week range

52W low $38.51 45.0% of range 52W high $85.25

Sector context · Healthcare

194 other Healthcare tickers are on Broken Stocks.

89 Red List
46 Amber
59 Watch
-36.0% Median decline

Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →

Questions about TARS

What people ask.

Why is TARS on Broken Stocks?

TARS qualifies for the Amber List on decline depth. It is down -30.2% from its rolling 252-day high of $85.25, set on 2025-12-09 — 170d ago.

Is TARS a falling knife?

Not by the strict technical definition. TARS is down -30.2% from its 52-week high, but that high was set 170d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. TARS is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.

Is TARS a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is TARS trading inside its 52-week range?

At $59.54, TARS sits 45.0% of the way from its 52-week low ($38.51) to its 52-week high ($85.25). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has TARS been declining?

The current 30.2% decline accrued over 170d, which annualizes to roughly -64.8% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does TARS compare to its sector?

There are 194 other Healthcare tickers on Broken Stocks: 89 Red, 46 Amber, 59 Watch, with 108 showing recovering structural signals. Median sector decline is -36.0% — TARS's decline is shallower than the sector median.

Does TARS's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-06) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.